13(top 5%)
papers
125(top 5%)
citations
5(top 5%)
h-index
9(top 5%)
g-index
14
all documents
139
doc citations
93
citing journals
3
times ranked

Top Articles

#TitleJournalYearCitations
1Effects of Seven Antibiotics on the Growth and Development of Phaenicia sericata (Diptera: Calliphoridae) LarvaeJournal of Medical Entomology199551
2The Role of Natural Killer Cells in Viral InfectionsScandinavian Journal of Immunology199741
3The pathogenesis of viral-induced diabetesClinical and Diagnostic Virology199816
4Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder CancerCancers202113
5Case of a Lung Mass due to Melioidosis in MexicoAmerican Journal of Case Reports20159
6Management of an Accessory Bile Duct Leak Following Pancreaticoduodenectomy: A Novel Approach Utilizing a Percutaneous and Endoscopic RendezvousACG Case Reports Journal20173
7Quality of life in sexual minorities following prostate cancer treatmentNature Reviews Urology20222
8Patient preferences in the treatment of genitourinary cancersNature Reviews Urology20232
9Intramyocardial Hemorrhage after Percutaneous Coronary InterventionEchocardiography20121
10Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 ResultsBlood20201
11Closing the Clinical Knowledge Gap: Achieving Collaborative Nursing Education Between Hospitalists and NursesCurrent Emergency and Hospital Medicine Reports20170
12NITRIC OXIDE PRESERVES PLATELET FUNCTION DURING IN VITRO VENTRICULAR ASSIST DEVICE CIRCULATIONASAIO Journal20010
13Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a StudyBlood20190